Free Trial

Colgate-Palmolive Stock: A Consumer Staple about to Hit New Highs

Colgate-Palmolive Co. overview: https://www.marketbeat.com/stocks/NYSE/CL/

Key Points

  • Colgate-Palmolive Co. issued robust results and guidance driven by price increases. 
  • The margin is on the mend and the analysts are raising their price targets. 
  • The stock isn't cheap but the yield is attractive and sustainable growth is on the table. 
  • 5 stocks we like better than Colgate-Palmolive.

Consumer staples stocks have moved higher across verticals, Colgate-Palmolive Co. NYSE: CL included. Despite still-rising costs, these companies exhibit robust pricing power and outperform their consensus expectations. Colgate Palmolive stock's first-quarter results sparked a round of analyst activity that has it on track to hit a new all-time high soon. At least six analysts have issued new price targets with the consensus on the rise and just below the current all-time high. Assuming this trend continues, the stock should be able to move into the all-time high territory before the summer, and it may trend higher through the end of the year. 

The analyst's sentiment has also trended higher. The analysts have the stock pegged at "moderate buy" after an upgrade from Morgan Stanley earlier in the year. That firm reiterated its "overweight" rating after the first-quarter release and raised its price target to $89 compared to the $84 Marketbeat.com consensus. In their view, the sales and margin news are good, but the outlook for sustainable growth is better. 

Colgate-Palmolive Raises Guidance and Prices 

Colgate-Palmolive had a robust quarter in which double-digit price increases were sufficient to offset a 2% decline in volume to produce 8.5% top-line growth. The $4.27 billion in revenue is up 8.5% compared to last year, beating the consensus estimate by 400 basis points. The strength was driven by gains in all divisions and categories, which is expected to persist. The margin news is mixed but favorable to higher share prices overall. The increase in pricing did not fully offset rising costs but resulted in a better-than-expected margin and outperformance on the bottom line. That left adjusted EPS at 73 cents and down YOY but three cents better than expected. 

“Despite continued pressure from raw and packaging material costs during the quarter, gross profit margin improved sequentially versus fourth quarter 2022, which helped fund a 14% increase in advertising in support of our pricing and robust innovation across all categories,” Wallace said. “We expect to drive further gross margin improvement in the balance of the year through continued strong pricing and the benefits from funding the growth and other productivity initiatives.”

The guidance is mixed but reveals a market that secretly feared the worst. The company guided revenue of 3% to 6% growth, which brackets consensus on the low side and for EPS to improve. There is no specific EPS guidance, only the expectation that the margin will improve again in the second quarter and the second half of the year. 

Colgate-Palmolive Offers Some Value and Yield to Investors 

Colgate-Palmolive is not a value relative to the broad market or its peers in the consumer staples sector, but it has attractions given the sector strength and the dividend. The stock trades at 25 times its earnings, consistent with peer Proctor & Gamble NYSE: PG but well below names like Church & Dwight Co. Inc. NYSE: CHD and The Clorox Company NYSE: CLX. The dividend isn’t as high as Clorox's 2.8%, but it is respectable at 2.4%, equal to the payout with PG stock. The stock is also a Dividend King with 59 years of increases in its history, so there is an element of safety attached to the valuation.

Shares of Colgate-Palmolive are melting higher on the news. The stock is up another 1% in the current session, reaching a six-month high. The next hurdle is near $82.50; a move above that level puts it on track to hit an all-time high soon. 

→ The Great Crypto Frenzy 2.0 is About to Start (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Thomas Hughes
About The Author

Thomas Hughes

Contributing Author

Technical and Fundamental Analysis

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Clorox (CLX)
3.7989 of 5 stars
$160.30+1.4%3.04%71.56Reduce$150.36
Procter & Gamble (PG)
4.4531 of 5 stars
$171.09+1.3%2.35%28.42Moderate Buy$176.21
Church & Dwight (CHD)
4.5156 of 5 stars
$101.61+1.4%1.11%31.26Hold$107.50
Colgate-Palmolive (CL)
4.5532 of 5 stars
$100.10+0.9%2.00%29.01Moderate Buy$106.00
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

Central Garden & Pet: Niche Focus, Big Growth Potential
Evolv Technologies Stock Up 59%: AI Security & 12-Month Forecast
Housing Prices Soar: These 3 Home Stocks May Benefit

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines